| |
INF beta-1b S/Q
|
INF beta-1a S/Q
|
INF beta-1a IM
|
Fingolimod
|
Others
|
|---|
|
Non-adherent
|
Adherent
|
Non-adherent
|
Adherent
|
Non-adherent
|
Adherent
|
Non-adherent
|
Adherent
|
Non-adherent
|
Adherent
|
|---|
|
Treatment satisfaction
|
Mean
|
75.25
|
83.14
|
76.04
|
83.25
|
75.82
|
81.83
|
81.16
|
81.33
|
78.53
|
84.50
|
|
SD
|
12.52
|
7.24
|
10.47
|
9.30
|
10.18
|
6.37
|
11.73
|
10.00
|
11.59
|
5.20
|
|
p
|
0.023
|
0.078
|
0.049
|
0.954
|
0.310
|
|
PDDS
|
Mean
|
2.3
|
3.9
|
2.9
|
4.0
|
2.4
|
1.3
|
2.7
|
3.4
|
3.7
|
3.0
|
|
SD
|
1.7
|
2.2
|
1.7
|
2.4
|
1.9
|
0.8
|
2.0
|
2.3
|
2.5
|
2.3
|
|
p
|
0.002
|
0.109
|
0.067
|
0.573
|
0.182
|
- INF beta-1b interferon beta-1b, INF beta-1a interferon beta-1a, S/Q subcutaneous, IM intramuscular
